Chemokines in the vascular inflammatory response of atherosclerosis.
about
Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytesRegulation of atherogenesis by chemokines and chemokine receptorsGenetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent mannerKinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their ReceptorsThe Role of CC-Chemokines in the Regulation of AngiogenesisThe Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic DiseasesDesign and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) studyIdentification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.Association between chemokine CXC ligand 12 gene polymorphism (rs1746048) and coronary heart disease: A MOOSE-compliant meta-analysis.Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaquesTGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.Reproducibility and concordance of differential DNA methylation and gene expression in cancer.Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies.A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.Chemokine receptor CCR5: from AIDS to atherosclerosisRole of chemokines in promoting instability of coronary atherosclerotic plaques and the underlying molecular mechanism.Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammationSTAT1-dependent signal integration between IFNγ and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosisModulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J miceER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells.Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis.Cytokines: roles in atherosclerosis disease progression and potential therapeutic targetsFactor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsBiological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases.Inhibitory effects and mechanisms of luteolin on proliferation and migration of vascular smooth muscle cells.ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPKInterleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.Circulating chemokine ligand levels before and after successful kidney transplantationPET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.Overexpression of complement component C5a accelerates the development of atherosclerosis in ApoE-knockout mice.Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammation.Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.Chemokines: established and novel targets in atherosclerosis.
P2860
Q26823331-C5C6613E-0351-465F-B84E-47833F22A880Q27003124-D56CD2AC-D869-4DB1-AA53-EA851B5DEEA4Q27316270-F2F34EB6-0E77-4A9B-9BE2-EECEFAC5FAD6Q27326691-99C1AE62-8FE2-40BE-8078-072060B4F572Q28077024-FEE5E6E5-8E76-47FD-A307-8280D5654F6EQ28080657-ECBEF9B1-E403-40BD-A261-7734C505ABA2Q30979831-B30A6C99-C9B3-4BFD-8F7D-959F8C34FF1DQ33591955-566FB41F-6005-460E-B8DB-76A844460696Q33818156-F86527AA-0013-43E1-AC0B-91BDF2443AD4Q33981521-62F33DFE-4746-475B-A979-FD8AC0350A8AQ34094979-3B9F7F2D-C042-42FA-B7C3-8AD0F61113A2Q34123835-7CF33EEE-2EC0-4F0B-8B0A-7056FBE8D0E9Q34196423-287109E9-D583-4EC3-AC1A-CEE031ACC471Q34448063-20FD9C22-F65F-4767-8822-EFE084DC4054Q34467421-C7266D00-CAFE-4A39-9C35-AA0D96E0A334Q34554918-9D923231-03D2-430D-9870-4F621A019DEAQ34609062-AC8C01B7-7463-4CEC-88ED-80E33D285E15Q34632459-3AA904AC-F3C4-4C23-BC05-0BB962C94127Q34672038-15C4B6FE-42BD-4FE2-B2C0-E316CB93A00EQ35062502-0BD5C849-E77F-4291-82DD-9A48B9494AF0Q35233878-4D808183-F17D-4721-8F02-3E54BD751FD3Q35493777-B14075F8-8013-4C90-814D-5362CFA63893Q35591762-F4C5000D-5E91-4771-B2AF-774555075195Q35976612-88C5A097-4F5B-4503-8964-F36AAED37C32Q35992029-742D493B-09A0-463A-8414-FD8B9403043AQ36064353-10E402AC-B7E7-4B81-A071-D393454EF7F7Q36080941-7D8A9E40-1CF8-4810-923B-79B37F9A3CA0Q36260190-1DBFBF98-4B92-499A-AE47-C68AE2502778Q36366126-24808D76-917B-4183-A3F2-E3133B3D1606Q36817578-34F87ABB-3CFA-4B2F-9F53-AF1D5199A22AQ37002562-ADEF92B8-B37E-4E55-A5A3-7D95B5845055Q37002637-691E0D6F-1588-407C-8ECD-B5E587B7A18FQ37114519-9713D2DA-E71D-4C6E-AACB-5AFF704746DAQ37369596-456651FE-F029-443D-8FA0-3DE89AA42E8BQ37383780-FD00AE74-CBB7-40C8-B016-CAD88188A078Q37636585-84225431-E6FE-4A7B-9C64-E19F1AB722CCQ37638355-91754CDB-1350-42AA-853A-A95750E51B83Q37724036-38BA38FB-9A5C-4A92-95F1-8EB2CAFE71C2Q37950457-D13BC249-5C7B-4DA7-B9BA-6BACADC0B599Q37950973-D1C4FD8B-88DC-44F4-A1CB-CD8DEF719BA1
P2860
Chemokines in the vascular inflammatory response of atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemokines in the vascular inflammatory response of atherosclerosis.
@en
Chemokines in the vascular inflammatory response of atherosclerosis.
@nl
type
label
Chemokines in the vascular inflammatory response of atherosclerosis.
@en
Chemokines in the vascular inflammatory response of atherosclerosis.
@nl
prefLabel
Chemokines in the vascular inflammatory response of atherosclerosis.
@en
Chemokines in the vascular inflammatory response of atherosclerosis.
@nl
P2860
P356
P1476
Chemokines in the vascular inflammatory response of atherosclerosis.
@en
P2860
P304
P356
10.1093/CVR/CVP391
P577
2009-12-09T00:00:00Z